A carregar...
The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling
AIMS: Although clinical guidelines advocate the use of the highest tolerated dose of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers after acute myocardial infarction (MI), the optimal dosing or the risk–benefit profile of different doses have not been fully identified. MET...
Na minha lista:
Publicado no: | ESC Heart Fail |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2018
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880661/ https://ncbi.nlm.nih.gov/pubmed/29341471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12249 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|